Diagnostic ECG Markets open at fresh highs with Key Players : Nihon Kohden Corporation, Philips Healthcare, GE Healthcare

“ECG” stands for electrocardiograph, which is a non-invasive tool used in cardiology. It has been around since the 1970s and is still used today, albeit with a new emphasis. The global diagnostic ECG market is expected to grow at a significant rate due to increasing prevalence of heart diseases worldwide. Rising incidences of cardiovascular diseases and various lifestyle-related diseases such as hypertensive heart disease, ischemic heart disease, peripheral artery diseases, and stroke is the major factor driving growth of the global diagnostic ECG market. For instance, as per the United States Centers for Disease Control and Prevention, heart failure was mentioned on 379,800 death certificates in 2018 in the U.S. Moreover, increasing geriatric population is also propelling the market growth.

Restraints:

Implementation of unfavorable reimbursement policies is the major factor restraining growth of the global diagnostic ECG market.

Regional Insights:

North America is expected to dominate the global diagnostic ECG market due to growing geriatric population, high per-capita income, and rising demand for minimally invasive procedures in the region. For instance, as per the United States Census Bureau, there were more than 54 million residents of 65 years and older as of 1 July 2019 in the U.S. Asia Pacific is expected to be the fastest growing market due to high prevalence of chronic diseases in the region.

Get “Business Insights” Research Sample Copy of This Report @ https://www.worldwidemarketreports.com/sample/491143

Competitive Section:

Key players of the global diagnostic ECG market are Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Medtronic, SCHILLER, Hill-Rom Holdings, BioTelemetry, BPL Medical Technologies, Shenzhen Mindray Bio-medical Electronics, ACS Diagnostics, BTL, Allengers Medical Systems, Ambu, Fukuda Denshi, Edan Instruments, Innomed Medical, Eccosur, Cardioline, Bionet, VectraCor, Norav Medical, Midmark Corporation, Nexus Lifecare, and OSI Systems.

In March 2018, Philips Healthcare launched a new cardiovascular product, IntelliSpace Cardiovascular 3.1.

In March 2018, BioTelemetry acquired Geneva Healthcare, a New Zealand based healthcare expert, in order to strengthen its position in remote cardiac monitoring devices market.

By Type

Resting & Stress ECG Systems
Holter Monitors

By Application

Hospitals
Clinics
Home

Talk to our Industry Expert for any quiry and customization @ https://www.worldwidemarketreports.com/quiry/491143

Contact Us:

Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com

Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.

This release was published on openPR.